Patents by Inventor Shoji Oda

Shoji Oda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9703282
    Abstract: A portable manipulation command input device, including a sub-console panel attachable to and removable from an automatic lathe apparatus main unit, and includes an input unit to receive input of a manipulation command to the automatic lathe apparatus main unit, a display unit to display information on the automatic lathe apparatus main unit, and a radio communication unit to communicate with the automatic lathe apparatus main unit. The sub-console panel includes a detection unit and a control unit formed with the automatic lathe apparatus main unit. The detection unit includes a radio ID tag and a radio ID reader detecting the sub-console panel being placed within a predetermined range of the automatic lathe apparatus main unit. Depending on a detection result by the detection unit, the control unit allows or restricts manipulations of the automatic lathe apparatus main unit, and allows display of the information even when restricting the manipulations.
    Type: Grant
    Filed: October 3, 2013
    Date of Patent: July 11, 2017
    Assignees: CITIZEN HOLDINGS CO., LTD., CITIZEN MACHINERY CO., LTD., MITSUBISHI ELECTRIC CORPORATION
    Inventors: Shigeo Yanagidaira, Takaichi Nakaya, Hitoshi Matsumoto, Kazuhiko Sannomiya, Shoji Oda
  • Patent number: 9546446
    Abstract: A polyethylene fiber characterized by having an intrinsic viscosity [?] of 0.8 dL/g or more and less than 5 dL/g; being composed of a repeating unit substantially derived from ethylene; having pores formed inside of the fiber; having an average diameter of the pores of ranging from 3 nm to 1 ?m when the diameter is measured, by each pore being approximated by a column, at a contact angle of 140 degrees, in a mercury intrusion method; a porosity of the pores of ranging from 1.5% to 20%; and having a tensile strength greater than or equal to 8 cN/dtex.
    Type: Grant
    Filed: October 10, 2010
    Date of Patent: January 17, 2017
    Assignee: Toyo Boseki Kabushiki Kaisha
    Inventors: Yasunori Fukushima, Shoji Oda, Minoru Masuda, Akira Hamano, Kunio Nishioka
  • Publication number: 20150227134
    Abstract: A portable manipulation command input device, including a sub-console panel attachable to and removable from an automatic lathe apparatus main unit, and includes an input unit to receive input of a manipulation command to the automatic lathe apparatus main unit, a display unit to display information on the automatic lathe apparatus main unit, and a radio communication unit to communicate with the automatic lathe apparatus main unit. The sub-console panel includes a detection unit and a control unit formed with the automatic lathe apparatus main unit. The detection unit includes a radio ID tag and a radio ID reader detecting the sub-console panel being placed within a predetermined range of the automatic lathe apparatus main unit. Depending on a detection result by the detection unit, the control unit allows or restricts manipulations of the automatic lathe apparatus main unit, and allows display of the information even when restricting the manipulations.
    Type: Application
    Filed: October 3, 2013
    Publication date: August 13, 2015
    Applicants: Citizen Holdings Co., Ltd.,, Mitsubishi Electric Corporation, Citizen Machinery Miyano Co., Ltd.,
    Inventors: Shigeo Yanagidaira, Takaichi Nakaya, Hitoshi Matsumoto, Kazuhiko Sannomiya, Shoji Oda
  • Publication number: 20150133439
    Abstract: The Present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
    Type: Application
    Filed: July 9, 2014
    Publication date: May 14, 2015
    Inventors: Anjali Pandey, Robert M. Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Junko Sasaki, Shoji Oda
  • Patent number: 8728619
    Abstract: The present invention provides a highly functional polyethylene fiber excellent in the cut resistance, has a high dimensional stability at about room temperature at which products are used, has a high shrinkage rate and stress, and excellent in forming processability when processed at a low temperature much less than a melting point of a polyethylene. And the present invention provides a highly functional polyethylene fiber excellent in processability at a low temperature, wherein an intrinsic viscosity [?] is higher than or equal to 0.8 dL/g, and is not higher than 4.9 dL/g, ethylene is substantially contained as a repeating unit, and a thermal stress at 40° C. is lower than or equal to 0.05 cN/dtex, and a thermal stress at 70° C. is higher than or equal to 0.05 cN/dtex, and is not higher than 0.25 cN/dtex. Further the present invention provides strings, ropes, woven/knitted textiles, and gloves thereof.
    Type: Grant
    Filed: January 24, 2011
    Date of Patent: May 20, 2014
    Assignee: Toyo Boseki Kabushiki Kaisha
    Inventors: Yasunori Fukushima, Shoji Oda, Akira Hamano, Minoru Masuda
  • Publication number: 20140000007
    Abstract: The present invention provides a highly functional polyethylene fiber exhibiting reduction of change in their physical properties in a wide range of temperatures for processing for products and in a wide range of temperatures for usage as products, thereby enabling improvement of dimensional stability. In addition, the present invention provides a highly functional polyethylene fiber exhibiting a high degree of dye exhaustion to be obtained in a simple dyeing operation, and excellent color fastness. The highly functional polyethylene fiber of the present invention is characterized in that an intrinsic viscosity [?] is higher than or equal to 0.8 dL/g, and not higher than 4.9 dL/g, ethylene is substantially contained as a repeating unit thereof, and a maximum thermal shrinkage stress is less than or equal to 0.4 cN/dtex in TMA (thermo-mechanical analysis), and a thermal shrinking percentage at 100° C. is less than or equal to 2.5%.
    Type: Application
    Filed: September 14, 2011
    Publication date: January 2, 2014
    Applicant: TOYOBO CO., LTD.
    Inventors: Yasunori Fukushima, Shoji Oda, Akira Hamano, Minoru Masuda
  • Publication number: 20130274252
    Abstract: The Present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
    Type: Application
    Filed: November 2, 2012
    Publication date: October 17, 2013
    Inventors: Anjali Pandey, Robert M. Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Junko Sasaki, Shoji Oda
  • Publication number: 20130029552
    Abstract: The present invention provides a highly functional polyethylene fiber excellent in the cut resistance, has a high dimensional stability at about room temperature at which products are used, has a high shrinkage rate and stress, and excellent in forming processability when processed at a low temperature much less than a melting point of a polyethylene. And the present invention provides a highly functional polyethylene fiber excellent in processability at a low temperature, wherein an intrinsic viscosity [?] is higher than or equal to 0.8 dL/g, and is not higher than 4.9 dL/g, ethylene is substantially contained as a repeating unit, and a thermal stress at 40° C. is lower than or equal to 0.05 cN/dtex, and a thermal stress at 70° C. is higher than or equal to 0.05 cN/dtex, and is not higher than 0.25 cN/dtex. Further the present invention provides strings, ropes, woven/knitted textiles, and gloves thereof.
    Type: Application
    Filed: January 24, 2011
    Publication date: January 31, 2013
    Applicant: TOYO BOSEKI KABUSHIKI KAISHA
    Inventors: Yasunori Fukushima, Shoji Oda, Akira Hamano, Minoru Masuda
  • Patent number: 8324205
    Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
    Type: Grant
    Filed: May 22, 2009
    Date of Patent: December 4, 2012
    Assignees: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Anjali Pandey, Robert M. Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Junko Sasaki, Shoji Oda
  • Publication number: 20120204322
    Abstract: The present invention provides a polyethylene fiber which can attain a high dye exhaustion rate, which indicates deep color, and which is excellent in dyeability and color fastness; a woven or knit textile that uses the polyethylene fiber, and that is excellent in cut-resistance and heat-retaining property, and a glove thereof. A polyethylene fiber of the present invention is characterized by having an intrinsic viscosity [?] of 0.8 dL/g or more and less than 5 dL/g; being composed of a repeating unit substantially derived from ethylene; having pores being formed from a surface of the fiber to an inside of the fiber; having an average diameter of the pores of ranging from 3 nm to 1 ?m when the diameter is measured, by each pore being approximated by a column, at a contact angle of 140 degrees, in a mercury intrusion method; a porosity of the pores of ranging from 1.5% to 20% 1; or a thermal conductivity in a fiber axis direction at a temperature of 300 K of ranging from 6 W/mK to 50 W/mK.
    Type: Application
    Filed: October 10, 2010
    Publication date: August 16, 2012
    Applicant: TOYO BOSEKI KABUSHIKI KAISHA
    Inventors: Yasunori Fukushima, Shoji Oda, Minoru Masuda, Akira Hamano, Kunio Nishioka
  • Patent number: 8022071
    Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
    Type: Grant
    Filed: December 18, 2007
    Date of Patent: September 20, 2011
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Anjali Pandey, Robert M. Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Junko Sasaki, Shoji Oda
  • Publication number: 20100113468
    Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
    Type: Application
    Filed: May 22, 2009
    Publication date: May 6, 2010
    Applicants: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Anjali Pandey, Robert M. Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Junko Sasaki, Shoji Oda
  • Patent number: 7560461
    Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: July 14, 2009
    Assignees: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Anjali Pandey, Robert M. Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Junko Sasaki, Shoji Oda
  • Publication number: 20090176780
    Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
    Type: Application
    Filed: December 18, 2007
    Publication date: July 9, 2009
    Applicants: Millennium Pharmaceuticals, Inc.
    Inventors: Anjali Pandey, Robert M. Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Nee Junko Irie Junko Sasaki, Shoji Oda
  • Patent number: 7329655
    Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomeruloscierosis.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: February 12, 2008
    Assignees: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Anjali Pandey, Robert M. Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Junko Sasaki, Shoji Oda
  • Publication number: 20060063770
    Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
    Type: Application
    Filed: August 8, 2005
    Publication date: March 23, 2006
    Applicants: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Anjali Pandey, Robert Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Junko Sasaki, Shoji Oda
  • Patent number: 6982266
    Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: January 3, 2006
    Assignees: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Anjali Pandey, Robert M. Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Junko Sasaki, Shoji Oda
  • Publication number: 20050288297
    Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
    Type: Application
    Filed: August 22, 2005
    Publication date: December 29, 2005
    Applicants: Millennium pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Anjali Pandey, Robert Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Junko Sasaki, Shoji Oda
  • Patent number: 6956039
    Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: October 18, 2005
    Assignees: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Anjali Pandey, Robert M. Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Junko Sasaki, Shoji Oda
  • Publication number: 20050101609
    Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method ol inhibiling kinascs and tre ating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention prtvides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
    Type: Application
    Filed: August 17, 2001
    Publication date: May 12, 2005
    Inventors: Anjali Pandey, Robert Scarborough, Kenji Matsuno, Michio Ichimura, Yuji Nomoto, Shinichi Ide, Eiji Tsukuda, Junko Sasaki, Shoji Oda